Search

Your search keyword '"Rothenberg, Marc E"' showing total 3,256 results

Search Constraints

Start Over You searched for: Author "Rothenberg, Marc E" Remove constraint Author: "Rothenberg, Marc E"
Sorry, I don't understand your search. ×
3,256 results on '"Rothenberg, Marc E"'

Search Results

1. Harnessing Digital Pathology And Causal Learning To Improve Eosinophilic Esophagitis Dietary Treatment Assignment

2. One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: A multisite randomized trial

3. Caregiver worry about COVID-19 as a predictor of social mitigation behaviours and SARS-CoV-2 infection in a 12-city U.S. surveillance study of households with children

4. Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis

5. Harnessing Artificial Intelligence to Infer Novel Spatial Biomarkers for the Diagnosis of Eosinophilic Esophagitis

7. Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis

10. Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis

11. Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis

14. PECNet: A Deep Multi-Label Segmentation Network for Eosinophilic Esophagitis Biopsy Diagnostics

19. Machine learning approach for biopsy-based identification of eosinophilic esophagitis reveals importance of global features

20. Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer

21. A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells

23. Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting

25. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

26. Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial

29. Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis

30. Local type 2 immunity in eosinophilic gastritis

32. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial

34. Genome-wide admixture and association analysis identifies African ancestry–specific risk loci of eosinophilic esophagitis in African Americans

36. High Discovery Rate of Duodenal and Gastric Eosinophilia in Patients With Unexplained Moderate–Severe Abdominal Symptoms: A Prospective US Multisite Study

37. The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders

39. Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study

40. Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

41. Development and Application of a Functional Human Esophageal Mucosa Explant Platform to Eosinophilic Esophagitis.

43. International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature

44. Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5

45. Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study

46. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions

48. Patient experience with eosinophilic esophagitis symptoms and impacts on daily life based on in-trial qualitative interviews.

49. An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes

Catalog

Books, media, physical & digital resources